Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Bundamedik Tbk (BMHS) vs Trimegah Karya Pratama Tbk. (UVCR) Price & Performance

Bundamedik TbkTrade
Trimegah Karya Pratama Tbk.Trade

Price performance (Past 24H)

Key statistics

Bundamedik Tbk vs Trimegah Karya Pratama Tbk. — how do they compare? Bundamedik Tbk trades at Rp176 (market cap 1.51T, 536.7K 24h volume), while Trimegah Karya Pratama Tbk. trades at Rp136 (market cap 268.02B, 36.96M 24h volume). The key difference: Bundamedik Tbk is far larger — about 5.6× Trimegah Karya Pratama Tbk.'s market cap, and Trimegah Karya Pratama Tbk. is more actively traded (36.96M versus 536.7K). Which is the better fit depends on your goals.

BMHSUVCR
Market Cap
1.51T268.02B
Volume
536.7K36.96M
Lot
5.37K369.56K
Turnover
93.41M5.02B
Average Price
174.05135.74
Value
93.41M5.02B
Indicative Equilibrium Price
176136
Indicative Equilibrium Volume
1002.08K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BMHS
View details
UVCR
View details

About Bundamedik Tbk

PT Bundamedik Tbk (the “Company”) was established on 13 April 1978 based on Notarial Deed No. 21 of Adlan Yulizar, S.H. The Company strated its commercial operations in 1978. The Company’s parent and ultimate parent of the group is PT Bunda Investama Indonesia.

Read more on BMHS

About Trimegah Karya Pratama Tbk.

PT Trimegah Karya Pratama Tbk (the Company) was established based on Notarial Deed No. 21 dated July 7, 2017 of Netty Maria Machdar, S.H. The Company started its commercial operations in 2018. The Company’s immediate parent company is PT Trimegah Sumber Mas, which was established and domiciled in Indonesia, while its ultimate Parent Company is PT Hutama Mulia Rajawali, which was established and domiciled in Indonesia.

Read more on UVCR